Yttrium-90 labeled basiliximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Yttrium-90 labeled basiliximab, covering 2025-03-20 to 2025-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma [Phase 1]